Baraclude

In the US, Baraclude (entecavir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.

US matches:

• Baraclude


• Baraclude Solution

UK matches:

• Baraclude 0.5 mg and 1.0 mg film coated tablets and Baraclude 0.05mg/ml oral solution (SPC)

Ingredient matches for Baraclude

Entecavir

Entecavir is reported as an ingredient of Baraclude in the following countries:

• Colombia


• Denmark


• Germany


• Indonesia


• Italy


• Luxembourg


• Peru


• Slovakia


• Slovenia


• South Africa


• Switzerland


• Thailand


• Tunisia


• Turkey

Entecavir monohydrate (a derivative of Entecavir) is reported as an ingredient of Baraclude in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Canada


• China


• Finland


• France


• Greece


• Hungary


• Ireland


• Mexico


• Netherlands


• New Zealand


• Norway


• Philippines


• Singapore


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.